COMMUNIQUÉS West-GlobeNewswire

Myriad Announces Prequel™ Prenatal Screen with Expanded Aneuploidy Analysis for all 23 Chromosome Pairs
11/02/2019
Enhanced Test Improves Detection of Chromosomal Abnormalities by 30 Percent(1) SALT LAKE CITY, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today [...]
Resonant Inc. Provides Update on Breakthrough XBAR™ Technology for 5G Mobile Devices
11/02/2019
First filters using XBAR™ resonators fabricated Presenting latest on XBAR this June at the International Microwave Symposium (IMS) in Boston, MA Company will be discussing its breakthrough XBAR technology at Mobile [...]
Flywheel Partners with Google Cloud to Provide Clinical Researchers with Advanced Cloud Technology and Machine Learning for Medical Imaging
11/02/2019
Breakthrough Cloud Platform and Machine Learning Technology to be Showcased at HIMSS19 in Orlando, Florida MINNEAPOLIS and MOUNTAIN VIEW, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Flywheel , provider of cloud-based [...]
Helix TCS: A Clear Market Leader in Cannabis Ancillary Services-- CFN Media
11/02/2019
SEATTLE, WA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Surgery Partners Announces Appointment of Eric Evans as Executive Vice President and Chief Operating Officer
11/02/2019
NASHVILLE, Tenn., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (the “Company”), a leading healthcare services company, today announced that Eric Evans has been appointed Executive Vice [...]
Arcturus Therapeutics Reassumes Full Worldwide Rights to ARCT-810, a Clinical Development Candidate for Ornithine Transcarbamylase (OTC) Deficiency
11/02/2019
SAN DIEGO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on the discovery, development and commercialization of therapeutics towards rare diseases, [...]
Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville
11/02/2019
Company Continues Long-Term, Strategic Relationship with Key Customer Recro Gainesville to be Exclusive Supplier of Ritalin LA ® and Focalin XR ® Capsules with “Total Revenue Per Capsule Economics” Expected to be [...]
Revive Closes Over 1.4 Million in Non-Brokered Private Placement
11/02/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]
Apellis Pharmaceuticals’ APL-2 Receives Fast Track Designation from the FDA for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
11/02/2019
New designation now includes all PNH patients WALTHAM Mass., and CRESTWOOD, Ky., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the [...]
RECORDATI: PRELIMINARY 2018 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +5.0%, EBITDA +9.8%, OPERATING INCOME +8.8%, NET INCOME +8.2%
11/02/2019
RECORDATI: PRELIMINARY 2018 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +5.0%, EBITDA +9.8%, OPERATING INCOME +8.8%, NET INCOME +8.2%. Consolidated revenues € 1,352.2 million, +5.0%. EBITDA (1) € [...]
Clementia Granted Rare Pediatric Disease Designation by FDA for Palovarotene for Fibrodysplasia Ossificans Progressiva
11/02/2019
MONTREAL, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]
Clementia reçoit la désignation de « maladie pédiatrique rare » (Rare Pediatric Disease designation) de la FDA pour le palovarotène contre la fibrodysplasie ossifiante progressive
11/02/2019
MONTRÉAL, 11 févr. 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq : CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]
Achillion Appoints Brian Di Donato as Chief Financial Officer
11/02/2019
NEW HAVEN, Conn., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by [...]
RadNet Signs a Definitive Agreement to Acquire the Imaging Operations of Kern Radiology, Further Expanding its Presence in Kern County and Bakersfield, California
11/02/2019
LOS ANGELES, Feb. 11, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has signed a [...]
Arrayit Corporation Nationwide Allergy Testing Network Doubles to More than 400 Healthcare Clinics
11/02/2019
Sunnyvale, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, reports that its nationwide allergy testing consortium has more than doubled in the past [...]
Immunicum AB (publ) Announces First Patient Treated in Phase Ib/II ILIAD Combination Trial
11/02/2019
Press Release 11 February 2019 Immunicum AB (publ) Announces First Patient Treated in Phase Ib/II ILIAD Combination Trial Immunicum AB (publ; IMMU.ST) announced today that the first patient has been treated in the Phase [...]
CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer
11/02/2019
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer Cambridge, UK, XX February 2019 : CMR Surgical Ltd, the British company developing [...]
Tetra Bio-Pharma Announces Stock Option Grants
09/02/2019
ORLEANS, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the "Corporation") (TSX VENTURE: TBP) (OTB: TBPMF), announces today that it has granted, pursuant to the Company's stock option [...]
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
09/02/2019
NEWS RELEASE REGULATED INFORMATION HERSTAL, BELGIUM and IRVINE, CA - February 9, 2019 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received on February 7, 2019 the following [...]

Pages